Oskar Hansson
Eli Lilly and Company
Oskar Hansson is listed as Eli Lilly and Company. Oskar is scheduled to speak at DGPPN Kongress 2026 on 27 November 2026.
Compiled from published conference agendas; not yet confirmed by Oskar. Is this you? Claim this profile.
About
Dr. Oskar Hansson gained his PhD in neurobiology in 2001 and his M.D. in 2005. He became senior consultant in neurology in 2012 at Skåne University Hospital, full professor of neurology in 2017 at Lund University, and Senior Vice President in 2024 at Eli Lilly.
Upcoming
DGPPN Kongress 2026 25 November 2026 – 28 November 2026
- Neurokognitive Erkrankungen: Früherkennung und Klassifikation Speaker · 27 November 2026
AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027
- FROM BIOMARKERS TO DIAGNOSIS: TRANSFORMING DEMENTIA CARE Speaker · 18 March 2027